DXCM Q1 2023 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$742M+17.9% YoY

Gross Profit

$463M62.4% margin

Operating Income

$47M6.4% margin

Net Income

$49M6.6% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

-9.0%

Cash Flow

Operating Cash Flow

$155M

Free Cash Flow

$81M

Stock-Based Comp.

$35M

Balance Sheet

Total Assets

$5.5B

Total Liabilities

$3.3B

Stockholders' Equity

$2.2B

Cash & Equivalents

$623M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$742M	$629M	+17.9%
Gross Profit	$463M	$398M	+16.2%
Operating Income	$47M	$41M	+14.3%
Net Income	$49M	$97M	-50.1%

Geographic Segments

UNITED STATES

$526M71%

Non-US

$216M29%